Statistics of generalized anxiety disorder
Pro Research Analysisby 
Searched over 200M research papers
Statistics of Generalized Anxiety Disorder (GAD)
Prevalence of Generalized Anxiety Disorder
Generalized Anxiety Disorder (GAD) is a common mental health condition characterized by chronic and excessive worry. The lifetime prevalence of GAD varies significantly across different regions and populations. According to a comprehensive study involving 26 countries, the lifetime prevalence of GAD is approximately 3.7%, with a 12-month prevalence of 1.8% and a 30-day prevalence of 0.8% . The prevalence is notably higher in high-income countries (5.0%) compared to middle-income (2.8%) and low-income countries (1.6%) . In a specific study conducted in Sweden among 75-year-olds, the 1-month prevalence of GAD was found to be 4.5% according to DSM-5 criteria .
Demographic Variations and Predictors
The prevalence of GAD also varies among different age groups and demographic factors. In children and adolescents, the lifetime prevalence rate is around 2.6% . Significant predictors of GAD in this age group include age, sex, maternal psychiatric history, maternal education, and place of residence . In adults, the prevalence of GAD symptoms can be assessed using the GAD-7 scale, which categorizes symptoms into minimal, mild, moderate, and severe .
Comorbidity with Other Disorders
GAD often coexists with other psychiatric disorders, which complicates its diagnosis and treatment. The comorbidity rate with mood disorders is particularly high, with studies indicating that 63% of individuals with GAD also suffer from mood disorders, and 51.7% have other anxiety disorders . In older adults, there is a significant overlap between GAD and depression, with 84.4% of those diagnosed with GAD also meeting criteria for depression . This high comorbidity rate underscores the need for comprehensive diagnostic assessments to address multiple conditions simultaneously.
Impact and Role Impairment
GAD is associated with substantial role impairment across various life domains. Approximately 50.6% of individuals with GAD experience severe role impairment, particularly in high-income countries . The disorder significantly affects social and occupational functioning, leading to increased risk for suicide and other adverse outcomes . In coronary heart disease patients, the prevalence of GAD is notably high at 10.94%, with a lifetime prevalence of 25.80%, further highlighting the disorder's impact on physical health .
Treatment and Dropout Rates
Despite the availability of effective treatments, GAD remains challenging to manage. Approximately half of the individuals with GAD seek treatment, with higher rates in those experiencing severe role impairment or comorbid disorders . However, dropout rates from psychotherapy for GAD are concerning, with a weighted mean dropout rate of 16.99% . This dropout rate is not significantly influenced by client demographics, symptom severity, or treatment type, indicating a need for more tailored and engaging therapeutic approaches .
Conclusion
Generalized Anxiety Disorder is a prevalent and debilitating condition with significant variations in prevalence across different populations and high comorbidity with other psychiatric disorders. The disorder leads to substantial role impairment and poses challenges in treatment adherence. Understanding the demographic predictors, comorbidity patterns, and impact of GAD is crucial for developing effective prevention and intervention strategies. Further research is needed to explore cross-national differences and improve treatment outcomes for individuals with GAD.
Sources and full results
Most relevant research papers on this topic
Cross-sectional Comparison of the Epidemiology of DSM-5 Generalized Anxiety Disorder Across the Globe
DSM-5 generalized anxiety disorder (GAD) is more prevalent than DSM-IV GAD and is associated with substantial role impairment, particularly in high-income countries.
The 1-month prevalence of generalized anxiety disorder according to DSM-IV, DSM-V, and ICD-10 among nondemented 75-year-olds in Gothenburg, Sweden.
GAD is common in 75-year-olds, but DSM-IV/V and ICD-10 definitions capture different individuals, with greater congruence between GAD and depression than between the two classification systems.
DOI